Session » Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

9:00AM-11:00AM

Abstract Number: 2285

12/15-Lipoxygenase Inhibition By ML351 Protects Against Uric Acid Crystal-Induced Acute Arthritis in Mice

9:00AM-11:00AM

Abstract Number: 2295

A Non-Linear Relationship Between Physical Activity and Serum Uric Acid Concentrations: Nhanes 2003-2004

9:00AM-11:00AM

Abstract Number: 2286

Bioresponsive Glucocorticoid-Loaded Microparticles to Prevent Acute Gout Flares

9:00AM-11:00AM

Abstract Number: 2293

Cardiometabolic Risk and Subclinical Urate Deposits in Patients with Symptomatic Hyperuricemia and Metabolic Syndrome

9:00AM-11:00AM

Abstract Number: 2290

Crystal-Proven Gout and Disease Severity Factors Influencing the Prevalence of Cardiovascular Diseases

9:00AM-11:00AM

Abstract Number: 2292

Decreased Endothelial and Smooth Muscle Responsiveness in the Vasculature of Gout Patients Compared with Healthy Controls: Relationship Between Flow- and Nitrate-Mediated Dilation, Serum Urate and CRP

9:00AM-11:00AM

Abstract Number: 2304

Decreased Occurrence of Colon Cancer Among Gout Patients: Assessment By Physician Diagnosis and Colonoscopy

9:00AM-11:00AM

Abstract Number: 2284

Differential Effect of MSU-Crystal Induced Inflammation on Macrophage Polarization

9:00AM-11:00AM

Abstract Number: 2274

Evidence of Phospho-Degron Regulating Expression of Urate Secretory Transporter ABCG2

9:00AM-11:00AM

Abstract Number: 2277

Exon Sequencing Reveals a Significant Burden of Non-Synonymous Variants in Both SLC22A11 (OAT4) and SLC22A12 (URAT1) in European Hyperuricemic Individuals

9:00AM-11:00AM

Abstract Number: 2282

Ferritin Levels Are Associated with Urate and Gout – a Role for Iron Metabolism in Gout ?

9:00AM-11:00AM

Abstract Number: 2275

Genome-Wide Association Study of Gout in New Zealand Polynesian People

9:00AM-11:00AM

Abstract Number: 2301

Gout and Subsequent Risk of Incident Erectile Dysfunction: A Population-Based Cohort Study from the United Kingdom

9:00AM-11:00AM

Abstract Number: 2291

Impact of Plasma Urate and Tophaceous Burden on Inflammatory Biomarkers of Cardiovascular Disease

9:00AM-11:00AM

Abstract Number: 2306

Improving Predictive Value of Gout Case Definitions in Electric Medical Records Utilizing Natural Language Processing: a Novel Informatics Approach

9:00AM-11:00AM

Abstract Number: 2298

Incident Risk of Acute Gout Among Active Smokers: Data from Nationwide Inpatient Sample

9:00AM-11:00AM

Abstract Number: 2270

Inflammasome/IL-1β Activation Induced By Calcium Pyrophosphate Dihydrate Crystals Is Mainly Driven By a P2X7 Receptor-Independent Potassium Efflux

9:00AM-11:00AM

Abstract Number: 2288

Inflammatory Status and Serum Uric Acid Determine High-Density Lipoprotein Cholesterol Levels in a Non-Rheumatic Population

9:00AM-11:00AM

Abstract Number: 2305

Mapping the Topography of Gout Flares: Solutions for Flare Reporting in Gout Clinical Trials

9:00AM-11:00AM

Abstract Number: 2280

Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout

9:00AM-11:00AM

Abstract Number: 2281

Monosodium Urate Monohydrate (MSU) Crystals Induces Cartilage Degeneration By Accelerating Hypertrophy and Mineralization.

9:00AM-11:00AM

Abstract Number: 2271

Mutation in Osteoprotegerin Gene: Early-Onset Osteoarthritis and Chondrocalcinosis in a US Family of Italian/German Ancestry

9:00AM-11:00AM

Abstract Number: 2289

Obesity and Echocardiographic Changes in the Different Stages of Gout

9:00AM-11:00AM

Abstract Number: 2276

Pleiotropic Effect of ABCG2 in Gout

9:00AM-11:00AM

Abstract Number: 2278

Precision of Gout Definitions for Population-Based Genetic Studies: Analysis of the UK Biobank

9:00AM-11:00AM

Abstract Number: 2299

Predictors of Mortality in People with Recent Onset of Gout: A Prospective Observational Study

9:00AM-11:00AM

Abstract Number: 2269

Proteinaceous Amorphous Calcium Carbonates As a Novel Family of Crystals in Synovial Fluid from Symptomatic Joints

9:00AM-11:00AM

Abstract Number: 2287

Serum Urate and Its Association with Endothelial Dysfunction in Young Adults

9:00AM-11:00AM

Abstract Number: 2297

Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial

9:00AM-11:00AM

Abstract Number: 2279

Soluble Urate: A Direct Mediator of Bone Turnover?

9:00AM-11:00AM

Abstract Number: 2283

Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1)

9:00AM-11:00AM

Abstract Number: 2296

The Influence of Androgen Deprivation Therapy on Serum Uric Acid Level

9:00AM-11:00AM

Abstract Number: 2272

The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide

9:00AM-11:00AM

Abstract Number: 2300

Tophaceous Gout and the Risk of Mortality: A General Population-Based Study

9:00AM-11:00AM

Abstract Number: 2273

Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations

9:00AM-11:00AM

Abstract Number: 2303

Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011

9:00AM-11:00AM

Abstract Number: 2294

Uric Acid Production and Blood Pressure: The Role of Uric Acid Concentration As Well As Uric Acid Production